Cervical Artery Dissection Completed Phase 3 Trials for Warfarin (DB00682)

IndicationStatusPhase
DBCOND0032810 (Cervical Artery Dissection)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00238667To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery DissectionTreatment